Cargando…

Analysis of the Influence of High-Dose rhGH Therapy on Serum Vitamin D and IGF-1 Levels in School-Age Children with Idiopathic Short Stature

OBJECTIVE: To discuss the influence of high-dose recombinant human growth hormone (rhGH) therapy on serum vitamin D and insulin-like growth factor-1 (IGF-1) levels in school-age children with idiopathic short stature (ISS). METHOD: A total of 103 school-age children with ISS were selected from June...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Juan, Zhang, Xuehui, Xie, Shuyong, Feng, Shuangshuang, Niu, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563117/ https://www.ncbi.nlm.nih.gov/pubmed/34737778 http://dx.doi.org/10.1155/2021/5776487

Ejemplares similares

GH Resistance Is a Component of Idiopathic Short Stature: Implications for rhGH Therapy
por: Savage, Martin O., et al.
Publicado: (2021)

Retracted: Analysis of the Influence of High-Dose rhGH Therapy on Serum Vitamin D and IGF-1 Levels in School-Age Children with Idiopathic Short Stature
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Clinical Characteristics of Short-Stature Patients With Collagen Gene Mutation and the Therapeutic Response to rhGH
por: Chen, Meiping, et al.
Publicado: (2022)

Novel pathogenic NPR2 variants in short stature patients and the therapeutic response to rhGH
por: Chen, Hong, et al.
Publicado: (2023)

Corrigendum: Clinical Characteristics of Short-Stature Patients With Collagen Gene Mutation and the Therapeutic Response to rhGH
por: Chen, Meiping, et al.
Publicado: (2022)

Diagnosis of Idiopathic GHD in Children Based on Response to rhGH Treatment: The Importance of GH Provocative Tests and IGF-1
por: Felício, João Soares, et al.
Publicado: (2019)

Inside the Noonan “universe”: Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns
por: Stagi, Stefano, et al.
Publicado: (2022)

Noonan syndrome: rhGH treatment and PTPN11 mutation
por: Wu, Xian, et al.
Publicado: (2023)

Response to Treatment with Recombinant Human Growth Hormone (rhGH) of Short Stature Children Born Too Small for Gestational Age (SGA) in Selected Centres in Poland
por: Glińska, Marta, et al.
Publicado: (2022)

Safety of Pediatric rhGH Therapy: An Overview and the Need for Long-Term Surveillance
por: Cianfarani, Stefano
Publicado: (2021)

Corroboration of Height Velocity Prediction Markers for rhGH With an Oral GH Secretagogue Treatment in Children With GHD
por: Blum, Werner F, et al.
Publicado: (2021)

Difficulties in Interpreting IGF-1 Levels in Short Stature Children Born Small for Gestational Age (SGA) Treated with Recombinant Human Growth Hormone (rhGH) Based on Data from Six Clinical Centers in Poland
por: Glińska, Marta, et al.
Publicado: (2023)

PSAT108 Impact of recombinant human growth hormone (rhGH) on skeletal muscle strength, power, endurance and agility in prepubertal boys with significant short stature: preliminary results
por: Welch, Lurah, et al.
Publicado: (2022)

Decreased Thyroxine Levels during rhGH Therapy in Children with Growth Hormone Deficiency
por: Witkowska-Sędek, Ewelina, et al.
Publicado: (2021)

Practical tools to identify short children born small-for-gestational-age eligible for rhGH treatment according to Italian regulation
por: Tornese, Gianluca, et al.
Publicado: (2019)

The Efficacy of GnRHa Alone or in Combination with rhGH for the Treatment of Chinese Children with Central Precocious Puberty
por: Wang, Mengjie, et al.
Publicado: (2016)

The phenotype and rhGH treatment response of ring Chromosome 15 Syndrome: Case report and literature review
por: Chen, Meiping, et al.
Publicado: (2021)

Investigating whether serum IGF-1 and IGFBP-3 levels reflect the height outcome in prepubertal children upon rhGH therapy: LG growth study database
por: Kim, Minsun, et al.
Publicado: (2021)

Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study
por: Soliman, Ashraf T, et al.
Publicado: (2019)

SUN-250 Natural History of Growth in Patients with SHOX Gene Haploinsufficiency and Impact of Treatment with rhGH in Adult Height
por: Menezes De Andrade, Nathalia, et al.
Publicado: (2019)

Ten years with biosimilar rhGH in clinical practice in Sweden – experience from the prospective PATRO children and adult studies
por: Lundberg, Elena, et al.
Publicado: (2020)

THU178 Predicted Adult Height Outcomes And Relation To Final Adult Height In Children With Isolated Idiopathic Growth Hormone Deficiency Treated With rhGH Therapy
por: Duong, Binh (Bailey), et al.
Publicado: (2023)

SAT-096 Response to RHGH Therapy in Children with Isolated Short Stature with or Without an Identified Genetic Cause
por: De Andrade, Nathalia Liberatoscioli Menezes, et al.
Publicado: (2020)

Effects of recombinant human growth hormone (rhGH) administration on body composition and cardiovascular risk factors in obese adolescent girls
por: Slattery, Meghan, et al.
Publicado: (2014)

mPEG-PLA and PLA-PEG-PLA nanoparticles as new carriers for delivery of recombinant human Growth Hormone (rhGH)
por: Ghasemi, Rohollah, et al.
Publicado: (2018)

Author Correction: mPEG-PLA and PLA-PEG-PLA nanoparticles as new carriers for delivery of recombinant human Growth Hormone (rhGH)
por: Ghasemi, Rohollah, et al.
Publicado: (2019)

In silico and in vitro analysis of a rational mutation in gIII signal peptide and its effects on periplasmic expression of rhGH in E. coli
por: Ghasemi, Fahimeh, et al.
Publicado: (2022)

SUN-254 A Long-Term, Phase IV Study of Omnitrope®, a Recombinant Human Growth Hormone (rhGH), in Short Children Born Small for Gestational Age (SGA)
por: Schwarz, Hans-Peter, et al.
Publicado: (2019)

An Approach to the Design of a Particulate System for Oral Protein Delivery .II. Preparation and Stability Study of rhGH-Loaded Microspheres in Simulated Gastrointestinal Fluids
por: Nafissi Varcheh, Nastaran, et al.
Publicado: (2011)

Phase 2 Randomized, Placebo-Controlled Clinical Trial of Recombinant Human Growth Hormone (rhGH) During Rehabilitation From Traumatic Brain Injury
por: Dubiel, Rosemary, et al.
Publicado: (2018)

Evaluation of Quality of Life in Children with GH Deficiency and Idiopathic Short Stature Using the Child Behavior Checklist
por: Tanaka, Toshiaki, et al.
Publicado: (2009)

GH Responsiveness Is not Correlated to IGF1 P2 Promoter Methylation in Children With Turner Syndrome, GHD and SGA Short Stature
por: Apel, Anja, et al.
Publicado: (2022)

Association of Polymorphisms in the Vitamin D Receptor Promoter with Idiopathic Short Stature
por: Choi, Seo Kyung, et al.
Publicado: (2013)

Effect of the parental origin of the X-chromosome on the clinical features, associated complications, the two-year-response to growth hormone (rhGH) and the biochemical profile in patients with turner syndrome
por: Álvarez-Nava, Francisco, et al.
Publicado: (2013)

Recombinant human growth hormone (rhGH) treatment of MKN-45 xenograft mice improves nutrition status and strengthens immune function without promoting tumor growth
por: Wei, Lianping, et al.
Publicado: (2019)

Corrigendum: GH responsiveness is not correlated to IGF1 P2 promoter methylation in children with Turner syndrome, GHD and SGA short stature
por: Apel, Anja, et al.
Publicado: (2022)

Therapeutic Efficacy and Safety of GH in Japanese Children with Down Syndrome Short Stature Accompanied by GH Deficiency
por: Meguri, Kyoko, et al.
Publicado: (2013)

Efficacy of zinc supplementation on growth and IGF-1 in prepubertal children with idiopathic short statures and low serum zinc levels
por: Yoshida, Kei, et al.
Publicado: (2020)

Characteristics of children with the best and poorest first- and second-year growth during rhGH therapy: data from 25 years of the Genentech national cooperative growth study (NCGS)
por: Kaplowitz, Paul B, et al.
Publicado: (2013)

Baseline IGFBP - 3 as the Key Element to Predict Growth Response to Growth Hormone and IGF - 1 Therapy in Subjects with Non - GH Deficient Short Stature and IGF - 1 Deficiency
por: Perez-Colon, Sheila, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_09rn6p799om2eihjn144u9kqvi